Azacitidine 58458-0002-02

Package NDC

58458-0002-02

Manufacturer: Reliance Life Sciences Private Limited
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous And Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: July 30, 2025
Listing Expires: December 31, 2026
Application: ANDA217453

Need to source Azacitidine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Azacitidine	100 mg/1

Drug Class

Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Selected Package

58458-0002-02Selected

1 VIAL, GLASS in 1 CARTON (58458-002-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS